Lukas J A Stalpers
Overview
Explore the profile of Lukas J A Stalpers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuijens A, Oei A, Franken N, Rasch C, Stalpers L
Curr Oncol
. 2025 Jan;
32(1).
PMID: 39851963
Normal tissue reactions vary significantly among patients receiving the same radiation treatment regimen, reflecting the multifactorial etiology of late radiation toxicity. Predicting late radiation toxicity is crucial, as it aids...
2.
IJff M, Mei X, Scutigliani E, Rodermond H, van Bochove G, Krawczyk P, et al.
Int J Hyperthermia
. 2025 Jan;
42(1):2450514.
PMID: 39837264
Efficacy of current treatment options for cervical cancer require improvement. Previous studies have shown the enhancing effects of the addition of PARP1-inhibitors to chemoradiotherapy and thermoradiotherapy. The aim of our...
3.
Dickhoff L, Scholman R, Barten D, Kerkhof E, Roorda J, Bouter A, et al.
Brachytherapy
. 2025 Jan;
24(1):197.
PMID: 39818421
No abstract available.
4.
Schoonhoven F, Aarts J, Fons G, Stalpers L, van Lonkhuijzen L, van der Velden J, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796654
Background: Guidelines recommend the extension of the pelvic radiotherapy volume to the para-aortic region in locally advanced cervical cancer and ≥3 suspicious pelvic lymph nodes (PLN) on imaging. Whether this...
5.
Olow A, Mueller S, Yang X, Hashizume R, Meyerowitz J, Weiss W, et al.
Clin Cancer Res
. 2024 Dec;
30(23):5494.
PMID: 39618199
No abstract available.
6.
Nuijens A, Oei A, Koster L, Hoebe R, Franken N, Rasch C, et al.
Radiat Oncol
. 2024 Sep;
19(1):116.
PMID: 39223539
Background: A predictive assay for late radiation toxicity would allow more personalized treatment planning, reducing the burden of toxicity for the more sensitive minority, and improving the therapeutic index for...
7.
Fobian S, Mei X, Crezee J, Snoek B, Steenbergen R, Hu J, et al.
J Med Virol
. 2024 Jun;
96(6):e29741.
PMID: 38922964
Cervical cancer is the fourth most common cancer in women worldwide and is caused by persistent infection with high-risk types of human papillomavirus (HPV). HPV viral load, the amount of...
8.
Olthof E, Wenzel H, van der Velden J, Stalpers L, Mom C, van der Aa M
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398108
Background: Modern treatment guidelines for women with advanced cervical cancer recommend staging using 2-deoxy-2-[F]fluoro-D-glucose positron emission computed tomography ([F]FDG-PET/CT). However, the risk of false-positive nodes and therapy-related adverse events requires...
9.
Olthof E, Bergink-Voorthuis B, Wenzel H, Mongula J, van der Velden J, Spijkerboer A, et al.
Insights Imaging
. 2024 Feb;
15(1):36.
PMID: 38332397
Objectives: Imaging is increasingly used to assess lymph node involvement in clinically early-stage cervical cancer. This retrospective study aimed to evaluate the diagnostic accuracy of MRI, CT, and [F]FDG-PET-CT. Methods:...
10.
Keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy
Dickhoff L, Scholman R, Barten D, Kerkhof E, Roorda J, Velema L, et al.
Brachytherapy
. 2024 Jan;
23(2):188-198.
PMID: 38296658
Purpose: Without a clear definition of an optimal treatment plan, no optimization model can be perfect. Therefore, instead of automatically finding a single "optimal" plan, finding multiple, yet different near-optimal...